My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Apple May Add $100 To Higher-End iPhone Model...
Nvidia Ecosystem ETF Debuts, Offering Exposur...
No Dot Plot, No Forward Guidance: Kevin Warsh...
Adobe Brings Creative AI Agent To Photoshop,...
Pfizer Stock Drops Today As CFO Steps Down In...
Tired Of Doomscrolling? Commodore's New $499...
Google Gemini Co-Lead Noam Shazeer Joins Open...
The 14-Point US-Iran Deal Broken Down: What I...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX)

    Overview
    current price
    $19.21
    $19.21
    change
    0.02 | 0.10%
    0.02 | 0.10%
    Yesterday's Close
    19.19
    open
    19.63
    volume
    0.77 M
    30d. avg volume.
    0.90 M
    1 day
    19.00 - 19.80
    52 weeks
    5.95 - 62.75
    p/e
    0.00
    beta
    1.0476
    market cap
    1.41 B
    dividend yield
    0.00%
    Industry
    -
    MLTX by TradingView
    News and Commentary
    10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move.High-short...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Pfizer Stock Drops Today As CFO Steps Down In August
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?